Curetis GmbH Max-Eyth-Str. 42 | 71088 Holzgerlingen | Germany Tel.: +49 (0)7031 49195 65 | Email: [email protected] Ares Genetics GmbH Karl-Farkas-Gasse 18 | 1030 Vienna | Austria Tel.: +43 (0)1 361 8880 | Email: [email protected] We offer a comprehensive portfolio of solutions for antimicrobial drug discovery, clinical development, and product lifecycle management. Our solutions aim at supporting data-driven target and lead prioritization, accelerating clinical trials, augmenting clinical data for regulatory submissions, and informed antimicrobial drug use for effective antibiotic stewardship post launch. Your partner for antimicrobial drug development Next Level Solutions for Molecular Microbiology & Data Intelligence in Antimicrobial Drug Development Member of ABx Development Informing Accelerate R&D Augment Clinical Data Prescribe Effectively www.curetis.com www.ares-genetics.com 00605 Rev. 1.0 © Curetis GmbH Caution – Investigational Device. Limited by Federal US Law to investigational Use. Not available for Sale in the United States. Advanced Bioinformatics and Artificial Intelligence for AMR AMR Target ID and MoA studies Lead compound prioritization AMR prediction at molecular level Deep pathogen characterization in discovery, clinical development, and surveillance The world’s most comprehensive database on the genetics of antimicrobial resistance 24/7 molecular testing In any lab or at point-of-care Results in 1-4 hours Comprehensive off-the-shelf panels Customized panels tailored to drug The any-plex solution for detection of pathogens and genetic antimicrobial resistance markers Rapid molecular diagnostics for clinical trials and LCM 1 A30 RQ Analzyer in development. Design concept. Actual product may differ. ARES Technology Platform Molecular microbiology data intelligence L4 C8 A50 A30 RQ 1